HomeAVTE • NASDAQ
add
Aerovate Therapeutics Inc
Previous close
$2.68
Day range
$2.63 - $2.77
Year range
$1.25 - $25.29
Market cap
238.55M USD
Avg Volume
416.22K
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.39M | -86.24% |
Net income | -2.52M | 89.14% |
Net profit margin | — | — |
Earnings per share | -3.15 | 89.16% |
EBITDA | -3.38M | 86.24% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 76.21M | -23.28% |
Total assets | 77.53M | -27.42% |
Total liabilities | 2.49M | -84.38% |
Total equity | 75.05M | — |
Shares outstanding | 828.14K | — |
Price to book | 0.03 | — |
Return on assets | -10.73% | — |
Return on capital | -11.13% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -2.52M | 89.14% |
Cash from operations | -2.38M | 89.94% |
Cash from investing | 12.85M | 45.48% |
Cash from financing | — | — |
Net change in cash | 10.47M | 172.86% |
Free cash flow | -1.90M | 87.66% |
About
Founded
2018
Headquarters
Website
Employees
4
